GAMCO INVESTORS, INC. ET AL - PROGENICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 127 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
GAMCO INVESTORS, INC. ET AL ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2016$108,000
+1.9%
17,000
-32.0%
0.00%0.0%
Q2 2016$106,000–25,000–0.00%–
 Download
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q4 2016.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders